The first question is of importance in the design and interpretation of biological studies of the mode of action of ECT. The second question is of practical interest to the treating psychiatrist when we ask how the speed of recovery is influenced by what the psychiatrist prescribes, that is, the number and frequency of treatments. These questions are little better answered now than 20 years ago. This may come as a surprise to many readers, who have been advised to use ECT when "seeking rapid improve ment" in depressive disorders ET Sub-Committee of the Research committee of the Royal college of Psychiatrists, 1989 . This lack of progress is attributable to a dearth of appropriately designed ECT studies.
Clare 1980 recognised that clinical impression, .sQmetimes referred to less charitably as dogma, remains an important influence oh the develdiithent of psychiatric practice in the absence of appropriate empirical studies. This point is particularly relevant to the use of ECT. clinical impressions of the answers to these two questions are far from uniform.
The prevailing research climate augurs ill for research studies to guide practice. The last study of the efficacy of ECT for depressive illness in the UK was completed in 1983 Gregory ci a!, 1985. Although research interest has not waned to the same extent in the USA, the National Advisory Mental Health Council 1988 , in its report to congress on thè Decade of the Brain', did not include ECT as one of the treatments for major mental illness that merited further research. The total research budget was over $100 million per annum and the failure to identify an important, widely used treatment must indicate the low priority given to ECT research by the single largest grant-giving body.
Recommended practice : 1969 and 1989 compared It is relevant to contrast the lack of progress in this important aspect of ECT practice with other changes in the recommended practice of ECT in the last two decades, many the result of empirical findings. Table 1 summarises the earlier recommendations that are taken from the third and last edition of Clinical Psychiatry Slater & Roth, 1969 . These recommendations are compared with those published by the ECT sub-committee 1989. One notable area where ffféiéëöTnmendaiiins have not changed con cerns the frequency of treatments, and no mention is made of the relationship between the frequency of treatment and antidepressant efficacy or timing of antidepressant effect. Attempts to reduce the adverse effects of ECT on memory figure importantly in the history of ECT research Abrams, 1988 . The 1989 recommendations add that treatment frequency should be only weekly if post-ECT confusion is marked, and daily.CF is not recommended because of severe memory impairment.
Empirical studies relevant to the 1989 recommendations
The selection of depressed patients to be treated by ECT has been influenced by a series of studies of the clinical prediction of ECT response Abrams, 1982 recommendations were that when sine-wave electrical stimulation is used, unilateral electrode placement is preferable because of its lesser adverse effects, and that bilateral electrode placement should be standard with brief-pulse stimulation, With briefpulse stimulation, missed seizures are more common with unilateral ECT Pettinati & Nilsen, 1985 ; older patients may respond better to bilateral ECT Abrams, 1986 , and unilateral electrode placement with a stimulus intensity just above seizure threshold may not be effective Sackeirn ci at, 1987.
There is now good evidence that generalised tonicclonic seizures are essential for therapeutic efficacy Daniel, 1983 . A close relationship between the length of individual seizures and therapeutic effect is unlikely, but seizures which last more than 25 seconds are likely to be of generalised tonic-clonic type Small et at, 1978. Two extra treatments given once recovery is apparent do not reduce the relapse rate in the three months after ECT in patients without any continuation of antidepressant treatment Barton ct at, 1973.
Antidepressant effect of ECT
Statements from recent postgraduate psychiatric textbooks, the Royal College of Psychiatrists and the American Psychiatric Association about the onset and rate of the antidepressant effect of ECT are summarised in Table 2 . There is no general agreement on the question of a delay in the onset of the antidepressant effect of ECT. At one extreme, .juarJcecLimproienicnaftera single EC1" is thought not to be attributable to ECT Kiloh cia!, 1988, or &jligiiJntgjiealth' to be Kaplan & Sadock, 1989 , and afthe other extreme it is stated that a few patients respond dramatically to one or two treatments Kendell & Zealley, 1988. Partly, this is the result of imprecision in the terminology used to describe treatment outcome in depressive illness Prien ci a!, 1991, for example a failure to distinguish clinical response, that is, improvement in depressive symptoms, from recovery, that is, complete remission of symptoms. The intermediate opinion is that there is only sllght improvement over the first few treatments, then increasing improvement with later treatments Gelder ct at, 1989. Several sources imply variable rates of improvement among depressed patients, but only Abrams 1988 lists factors that may be associated with such variation. The same author notes that the maximum benefit from an individual seizure may take a week or more to develop, although this view is not supported by a reference, Unlike some earlier textbooks of psychiatry, those summarised in Table 2 Recovery after 1 ECT probably natural`[ No precise rules; 2-6 per week depending remission or incorrect diagnosis electrode placeiiiñraiidin ividual patient Response to 1st and 2nd treatments highly 2-3 per week; daily should not be given correlated with overall change second ECT, the patient was better for part of the afternoon, and after the third and fourth treatments the improvement extended to the next treatment day.
Empirical studies
Until recently, in most ECT studies the timing of assessments was ordered to allow comparison with the effects of antidepressant drugs, for example after six administrations of ECT, at four weeks, or at discharge see reviews by Barton, 1977; Avery & Winokur, 1977 . Recent controlled trials of ECT often included more frequent assessments see Crow & Johnstone, 1986 , but did not distinguish between rates of improvement of those patients who go on to recover with ECT and those who make only a partial recovery or do not improve at all.
Katz et a! 1987, writing as part of the National
Institute of Mental Health Collaborative Program on the Psychobiology of Depression, emphasised that the process of recovery during treatment for depressive illness must be studied separately in those patients who clearly go on to recover. This point is important and has been neglected in almost all ECT studies. Additionally, most patients in ECT studies also receive concomitant psychotropic drugs, which seems likely to hinder interpretation of results. Even benzodiazepine drugs may confound the pattern of improvement, either by diminishing certain symptoms of depressive illness or by com promising the therapeutic effects of ECT Pettinati et a!, 1990. Of all the ECT studies specifically designed to assess rate of improvement, only one Post et a!, 1987 concerned drug-free depressed patients who clearly recovered with treatment. Rapid onset of antidepressant effect during a course of bilateral sinewave ECT was observed in all eight depressed patients studied. There are two other relevant studies, but either patients were not drug-free, or recovered patients were not considered separately from nonrecovered. Rich & Black 1985 observed the greatest reduction in depression ratings after the first unilateral brief-pulse ECT, and Price et a! 1978 found that the improvement after the first two bilateral sine-wave ECTs was closely correlated with improvement over a course of treatment.
The preceding findings, while clearly preliminary, do not support the views that there is a delay in the onset of the antidepressant effect of ECT and that little improvement occurs early in a course of treatment.
Frequency of treatment
Psychiatric textbooks Abrams 1988 considered differences in the preferred frequency of treatment were more to do with`personality characteristics' and daily routine' of the treating psychiatrists, rather than any theoretical basis.
In the management of severely ill patients, two different approaches are recommended, namely an increase in the frequency of treatments per week and increasing the number of treatments given per anaesthetic. None of the textbooks that recommended either practice cited published studies that supported an increased rate of antidepressant effect. The most recent Task Force Report on ECT by the American Psychiatric Association 1990 supports the use of daily ECT in severely ill patients and, moreover, recommends factors that must be specified in multiple inductions of seizures during the one anaesthetic multiple monitored ED', or MMECT. The Task Force noted that a`substantial minority' of practitioners use MMECT at least occasionally. In contrast, the Royal College of Psychiatrists stated. that daily ECT should not be given and made no mention of MMECT.
Variations in recommended psychiatric practice are not unique to ECT. ECT is, however, unique among commonly used treatments in that each application inevitably leads to a variable period of drowsiness, confusion and anterograde amnesia, commonly causes headache and nausea, and may lead to the occasional loss of personal memories; moreover, each application requires a brief anaes thetic that involves additional risks of morbidity and mortality that are slight but never negligible American Psychiatric Association, 1990. MMECT is also associated with an increased risk of prolonged seizures or status epilepticus Abrams, 1988. Moreover, TlYâiiblflhidiictiöiiTliliTie more improvement between the outset of treatment and the day after the fourth session of treatment. Double induction was also superior when analysis was carried out separately, both in deluded patients and in patients who clearly recovered with ECT.
There are insufficient data to determine the optimum frequency in clinical practice. In the I management of severely ill patients, two different strategies are ië5iTimended. The first involves increasing the number of treatment sessions per week, even up to daily sessions, and the second strategy is to increase the number of seizures induced during the one anaesthetic. There are no comparativè studies of these two strategies.
Practical and theoretical implications
The presumed relationship between the onset of the of ECT are without antidepressant effect. This opinion may be apparently self-fulfilling if patients are not reviewed until they have had several treatments in a course of ECT. The prescription of a fixed number of treatments was not recommended by any of the sources reviewed, but a future study to establish the antidepressant effect of early treatments may influence the use of ECT.
The lack of evidence concerning the cost and benefit of various frequencies of ECT means that its use more often rests on personal preference than an adequate theoretical basis Abrams, 1988. In the UK, ECT is usually given twice per week and an ECT course consists of just over six treatments Pippard & Ellam, 1981 , whereas in the USA, ECT is usually given three times per week and a course consists of ten treatments Lerer & Shapira, 1986 . In recent textbooks, the recommended frequency in the routine practice of ECT varied from one to five bilateral treatments per week. This discrepancy would not be tolerated in the recommended therapeutic dose of a newly introduced antidepressant drug. There is no general agreement on the optimum treatment of patients who are suicidal or refusing to eat and dim and in whom a ra improvement wo e esira le. The recommendations given by several of the textbooks conflicts with that of the ECT Sub Committee, who noted that there is no evidence that daily ECT speeds recovery.
There is considerable controversy about the significance of any apparent antidepressant effect early in a course of ECT. Several authors suggest this phenomenon is worth studying. Price eta! 1978 suggest, for example, that the clinical response to the first one or two treatments may prove helpful in forecasting the likelihood of eventual recovery after a course of ECT. Fink1979 argues further that the identification of characteristics of depressed patients who respond rapidly to ECT may form the basis of a future subclassification of depressive illness. The ECT Sub-Committee's guidelines noted that a few depressed patients make a rapid response to one to two treatments and so make further treatment unnecessary. In contrast, Kiloh ci a! 1988 remark that marked improvement after a single treatment is not related to ECT itself, but probably reflects a natural remission or the incorrect diagnosis of depression. By extension, Pande ci a! 1988, in their study of clinical predictors of response to ECT in depressive illness, excluded from the study any patient who did not receive at least five treat ments. These conflicts about the scientific validity, theoretical and clinical significance of an anti depressant effect early in a course of ECT remain unresolved.
Opinions about the relationship between the antidepressant effect of ECT and individual treat ments are important in determining the design and interpretation of biological studies of the mode of action of ECT. In an influential article, Kety 1974 stated that a single treatment was insufficient to produce a detectable clinical effect, suggesting that the acute effects of a single seizure on monoamine function were not likely to account for the anti depressant effect of ECT. This statement was made without reference to any clinical studies, but has been repeated in textbooks with reference to any of the acute biochemical effects of ECT Fink, 1979; Lerer ci a!, 1984; Kiloh ci a!, 1988 and applied in important studies of the mechanism of the anti depressant effect of ECT e.g. Grahame-Smith eta!, 1978 . In other words, this opinion has directed biological studies away from the acute effects of cerebral seizure activity to effects that emerge only after a series of treatments.
It is not disputed that most depressed patients who recover with ECT do so only after several treatments, but the statement that a single treatment is without any clinical effect is, to say the least, contentious in view of the clinical studies above that detected a rapid onset of antidepressant effect during a course of ECT. In the most recent review of the psycho pharmacology of repeated seizures, Green & Nutt 1987 repeated the statement that a single admini stration of ECT is insufficient to produce any detectable clinical improvement, but with an added caveat that some biochemical change must be occurring after even a single treatment, which results in the long-term alterations responsible for the antidepressant effect of ECT.
Our own series of studies support the view that a biochemical change after a single treatment can be associated with the subsequent antidepressant effect Scott ci a !, 1986 , 1989 , 1991 Whalley ci a!, 1987 . We found that a hormonal effect of ECT detectable within two minutes of the first ECT the release of the oxytocin-associated neurophysin correlated with the extent of eventual improvement in symptoms of depressive illness over the whole course of treat ment. Neurophysin release was not simply an epiphenomenon of cerebral seizure activity Scott ci a!, 1989. Surprisingly, the release of oxytocin itself may not be related to clinical outcome Smith ci a!, 1990.
Methodological considerations for future studies Few ECT studies are designed to study the onset of improvement in symptoms of depressive illness or its relationship to the number and frequency of treatments. Given the considerable variations in contemporary recommendations and ECT practice, it will be necessary to assign priority to a few questions. Firstly, it is of considerable theoretical importance to establish to what extent treatments early in a course of ECT have detectable anti depressant effects. Thereafter it may become informative to ask in which type of depressed patient or depressive illness this is so. An appropriately designed study could simultaneously investigate questions of direct practical relevance. A clear understanding of the effects of treatment frequency on the rate of improvement and final antidepressant efficacy is lacking. Furthermore, there are few data to guide practice in the management of patients in whom the need for clinical improvement is urgent and may be life-saving. Were it to be established that, say, thrice-weekly treatment brings about more rapid improvement than twice-weekly treatment, an appropriate design would be to compare thriceweekly treatment with a yet more frequent treatment schedule. if twice-and thrice-weekly treatments are equivalent in their rate of antidepressant effect, it would be more appropriate to compare, say, double induction of seizures with single induction, both given at the same frequency. Such studies could not be restricted to the most severely ill or disturbed patients, because patients would be free of psycho tropic drugs throughout the course of ECT to assist interpretation of the results. This is not routine in the UK, but has become recommended practice in the USA Abrams, 1988 ; American Psychiatric Association, 1990 and should not, in a research context, raise ethical problems.
Frequent assessment of patients would be required, and difficulties would arise in the use of observer rating scales of depression because so few were designed to be sensitive to short-term change. One exception is the Montgomery and Asberg Depression Rating Scale Montgomery & Asberg, 1979 , which can be used daily with success, at a fixed time each afternoon Dykes, 1988. Daily assessment would be complemented usefully by the inclusion of subjective visual analogue scales. An anecdotal report from the earliest days of ECT Sargent & Slater, 1944 described dramatic improvements in the motor signs of serious mental illness early in a course of ECT, a suggestion supported by a small preliminary study by Browning & Cowen 1986 , which suggests that some specific symptoms of depressive illness may show a distinct pattern of improvement during a course of ECT. Unfortunately, such study will require large numbers of patients and the develop ment of new rating scales sufficiently sensitive to small changes in individual symptoms. Whether truly blind rating by observers that is, without any knowledge of exposure to real or sham ECT is feasible is open to question, but raters would be blinded to the different frequencies of real ECT.
Several factors relating to the patient, the illness, and the details of ECT treatment are likely to affect the relationship of antidepressant efficacy to the number and frequency of treatments. Three are of such importance that they should be considered in the design of the study. Firstly, the rate of response is likely to be different in unilateral and bilateral ECT Abrams, 1986 . However, since bilateral ET is the latera.lity recommended by the Royal College of Psychiatrists, it might be preferred to make bilateral ECT the standard. It is not yet known whether bilateral ECT is similar to unilateral ECT in that stimulus intensity affects the rate of clinical improve ment; nevertheless, stimulus intensity would have to be standardised. Secondly, depressed patients who are psychotic may respond particularly well to ECT Pande eta!, 1990 , and allocation of patients should ensure that deluded patients are equally distributed in samples. Thirdly, patients who have failed to respond to a therapeutic dose of an antidepressant drug may not respond so well to ECT Prudic et a!, 1990 , and again allocation of patients should take account of treatment resistance.
Such stratificationihave considerable implications for the minimum sample size in any proposed study. This point requires further emphasis because of the need to study the pattern of recovery among those patients who clearly recover with ECT, and implies that meaningful results would depend on the recruitment of a large sample of depressed patients.
Conclusions
The selection of depressed patients to receive ECT and the recommended practice of the administration of ECT have changed considerably over the past 20 years. Most recent changes were made with a view to minimising the adverse cognitive effects of ECT. One crucial area of practice that has not been subject to appropriate research concerns the relationship between the antidepressant effect of ECT and the number and frequency of treatments.
Virtually all depressed patients who recover with ECT require at least several treatments to bring about complete remission, but this does not necessarily mean that treatments early in a course of ECT are without antidepressant effect. Some textbooks state that there is such a delay in the onset of anti depressant effect, and this has probably influenced clinical practice, although the few small studies specifically designed to answer this question do not There is a pressing need to establish to what extent the rate of clinical improvement is influenced by the prescribing habits of the treating psychiatrist. Twiceweekly ECT is the usual practice in the UK and threè ilijies weeklY is the usual practice in the USA. This difference reflects personal preference rather than any theoretical standpoint, although the clinical implic'ations are now under study. Confirmation or refutation that increasing the frequency of treatment äiihances the rate of antidepressant effect of ECT would be of considerable clinical importance and would help direct research.
Little research into ECT is being conducted in the UK. Whether this low level of research activity is a matter of priority or fashion is open to debate, but these topics are worthy of research. A better understanding of the relationship between clinical improvement and the frequency of treatment would maximise the therapeutic benefit and minimise the cost in terms of adverse cognitive effectCThe cliñithl fispons&idiiièiiiiFdiWöii twoi?Eãiittents may be helpful in predicting which patients will go on to a full recovery. Refutation of this suggestion will be just as important in clinical practice. The character isation of depressed patients who make a rapid improvement with ECT may lead to an improved subclassification of depressive illness, and the identification of which, if any, symptoms or signs of depressive illness characteristically improve early in a course of ECT may provide insights into the temporal sequence of the biological effects of ECT. Questions like these will not be answered properly unless ECT researchers apply and develop methods of clinical rating designed for frequent use and sensitive to small changes in symptoms of depression.
Electroconvulsive therapy is unique among physical treatments for depressive illness, in that the onset of its effects on cerebral function can be defined precisely in time by electroencephalogram, offering many opportunities for the biological study of its antidepressant effects. Biological studies in both man and animal must be designed to take account of the onset and rate of the antidepressant effect of ECT in depressed patients. The opinion that the first one or two treatments are without any detectable anti depressant effect has directed biological studies away from the acute effects of cerebral seizure activity, yet is without confirmation in an appropriately designed study of a representative sample of depressed patients who recovered with ECT. 
